Daniel Triner1, Samantha N Devenport1, Sadeesh K Ramakrishnan1, Xiaoya Ma1, Ryan A Frieler1, Joel K Greenson2, Naohiro Inohara2, Gabriel Nunez3, Justin A Colacino4, Richard M Mortensen5, Yatrik M Shah6. 1. Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan. 2. Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan. 3. Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan. 4. Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan; Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan. 5. Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan; Internal Medicine Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan. 6. Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan; Internal Medicine Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: shahy@umich.edu.
Abstract
BACKGROUND & AIMS: Neutrophils are among the most prevalent immune cells in the microenvironment of colon tumors; they are believed to promote growth of colon tumors, and their numbers correlate with outcomes of patients with colon cancer. Trials of inhibitors of neutrophil trafficking are underway in patients with cancer, but it is not clear how neutrophils contribute to colon tumorigenesis. METHODS: Colitis-associated colon cancer was induced in mice with conditional deletion of neutrophils (LysMCre;Mcl1fl/fl) and wild-type littermates (LysMCre;Mcl1wt/wt, control mice) by administration of azoxythmethane and/or dextran sulfate sodium. Sporadic colon tumorigenesis was assessed in neutrophil-deficient and neutrophil-replete mice with conditional deletion of colon epithelial Apc (Cdx2-CreERT2;Apcfl/fl). Primary colon tumor tissues from these mice were assessed by histology, RNA sequencing, quantitative polymerase chain reaction, and fluorescence in situ hybridization analyses. Fecal and tumor-associated microbiota were assessed by 16s ribosomal RNA sequencing. RESULTS: In mice with inflammation-induced and sporadic colon tumors, depletion of neutrophils increased the growth, proliferation, and invasiveness of the tumors. RNA sequencing analysis identified genes that regulate antimicrobial and inflammatory processes that were dysregulated in neutrophil-deficient colon tumors compared with colon tumors from control mice. Neutrophil depletion correlated with increased numbers of bacteria in tumors and proliferation of tumor cells, tumor-cell DNA damage, and an inflammatory response mediated by interleukin 17 (IL17). The 16s ribosomal RNA sequencing identified significant differences in the composition of the microbiota between colon tumors from neutrophil-deficient vs control mice. Administration of antibiotics or a neutralizing antibody against IL17 to neutrophil-deficient mice resulted in development of less-invasive tumors compared with mice given vehicle. We found bacteria in tumors to induce production of IL17, which promotes influx of intratumor B cells that promote tumor growth and progression. CONCLUSIONS: In comparisons of mice with vs without neutrophils, we found neutrophils to slow colon tumor growth and progression by restricting numbers of bacteria and tumor-associated inflammatory responses.
BACKGROUND & AIMS: Neutrophils are among the most prevalent immune cells in the microenvironment of colon tumors; they are believed to promote growth of colon tumors, and their numbers correlate with outcomes of patients with colon cancer. Trials of inhibitors of neutrophil trafficking are underway in patients with cancer, but it is not clear how neutrophils contribute to colon tumorigenesis. METHODS:Colitis-associated colon cancer was induced in mice with conditional deletion of neutrophils (LysMCre;Mcl1fl/fl) and wild-type littermates (LysMCre;Mcl1wt/wt, control mice) by administration of azoxythmethane and/or dextran sulfate sodium. Sporadic colon tumorigenesis was assessed in neutrophil-deficient and neutrophil-replete mice with conditional deletion of colon epithelial Apc (Cdx2-CreERT2;Apcfl/fl). Primary colon tumor tissues from these mice were assessed by histology, RNA sequencing, quantitative polymerase chain reaction, and fluorescence in situ hybridization analyses. Fecal and tumor-associated microbiota were assessed by 16s ribosomal RNA sequencing. RESULTS: In mice with inflammation-induced and sporadic colon tumors, depletion of neutrophils increased the growth, proliferation, and invasiveness of the tumors. RNA sequencing analysis identified genes that regulate antimicrobial and inflammatory processes that were dysregulated in neutrophil-deficient colon tumors compared with colon tumors from control mice. Neutrophil depletion correlated with increased numbers of bacteria in tumors and proliferation of tumor cells, tumor-cell DNA damage, and an inflammatory response mediated by interleukin 17 (IL17). The 16s ribosomal RNA sequencing identified significant differences in the composition of the microbiota between colon tumors from neutrophil-deficient vs control mice. Administration of antibiotics or a neutralizing antibody against IL17 to neutrophil-deficient mice resulted in development of less-invasive tumors compared with mice given vehicle. We found bacteria in tumors to induce production of IL17, which promotes influx of intratumor B cells that promote tumor growth and progression. CONCLUSIONS: In comparisons of mice with vs without neutrophils, we found neutrophils to slow colon tumor growth and progression by restricting numbers of bacteria and tumor-associated inflammatory responses.
Authors: James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss Journal: Appl Environ Microbiol Date: 2013-06-21 Impact factor: 4.792
Authors: Eric L Campbell; Walter J Bruyninckx; Caleb J Kelly; Louise E Glover; Eóin N McNamee; Brittelle E Bowers; Amanda J Bayless; Melanie Scully; Bejan J Saeedi; Lucy Golden-Mason; Stefan F Ehrentraut; Valerie F Curtis; Adrianne Burgess; John F Garvey; Amber Sorensen; Raphael Nemenoff; Paul Jedlicka; Cormac T Taylor; Douglas J Kominsky; Sean P Colgan Journal: Immunity Date: 2014-01-09 Impact factor: 31.745
Authors: Xiang Xue; Matthew Taylor; Erik Anderson; Cathy Hao; Aijuan Qu; Joel K Greenson; Ellen M Zimmermann; Frank J Gonzalez; Yatrik M Shah Journal: Cancer Res Date: 2012-03-14 Impact factor: 12.701
Authors: Thomas Jamieson; Mairi Clarke; Colin W Steele; Michael S Samuel; Jens Neumann; Andreas Jung; David Huels; Michael F Olson; Sudipto Das; Robert J B Nibbs; Owen J Sansom Journal: J Clin Invest Date: 2012-08-27 Impact factor: 14.808
Authors: Alain P Gobert; Yvonne L Latour; Mohammad Asim; Daniel P Barry; Margaret M Allaman; Jordan L Finley; Thaddeus M Smith; Kara M McNamara; Kshipra Singh; Johanna C Sierra; Alberto G Delgado; Paula B Luis; Claus Schneider; M Kay Washington; M Blanca Piazuelo; Shilin Zhao; Lori A Coburn; Keith T Wilson Journal: Gastroenterology Date: 2021-11-10 Impact factor: 22.682
Authors: Hannah N Bell; Ryan J Rebernick; Joshua Goyert; Rashi Singhal; Miljan Kuljanin; Samuel A Kerk; Wesley Huang; Nupur K Das; Anthony Andren; Sumeet Solanki; Shannon L Miller; Peter K Todd; Eric R Fearon; Costas A Lyssiotis; Steven P Gygi; Joseph D Mancias; Yatrik M Shah Journal: Cancer Cell Date: 2021-12-23 Impact factor: 38.585
Authors: Samantha N Devenport; Rashi Singhal; Megan D Radyk; Joseph G Taranto; Samuel A Kerk; Brandon Chen; Joshua W Goyert; Chesta Jain; Nupur K Das; Katherine Oravecz-Wilson; Li Zhang; Joel K Greenson; Y Eugene Chen; Scott A Soleimanpour; Pavan Reddy; Costas A Lyssiotis; Yatrik M Shah Journal: JCI Insight Date: 2021-06-17